The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma
Open Access
- 11 February 2022
- journal article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Care
- Vol. 7 (1), 191-196
- https://doi.org/10.31557/apjcc.2022.7.1.191-196